Plain-English translation of NCT02917707 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting tissue samples from people with colorectal cancer to understand the genetic and protein changes that happen when the disease spreads to the liver. By studying normal colon tissue, cancer tissue, and tissue from liver metastases side by side, scientists hope to discover what makes some cancers more likely to spread than others. This knowledge could help doctors develop better treatments in the future.
Colorectal cancer that spreads to the liver is a serious form of the disease, but doctors don't fully understand why it happens or how to predict which patients are at highest risk. This study aims to fill that gap by analyzing the molecular changes that occur during cancer spread, which could lead to new ways to prevent or treat metastatic disease.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect tissue samples during your surgery or biopsy — these are often samples that would be removed anyway as part of your regular cancer care. The study team will then analyze these samples in the laboratory using advanced genetic and protein testing techniques. You may be asked to provide a blood sample as well. There are no ongoing medication doses or regular clinic visits required beyond your standard cancer care appointments.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China
Sponsor
Da Fu
Collaborators
Ganzhou City People's Hospital
Enrollment target
~1,000 participants
Started
January 2016
Primary completion
December 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in September 2016.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Da Fu, Ph.D.
the Shanghai Tenth People's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.